Breakthrough Invasive Candidiasis in Patients on Micafungin

Autores
Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; Alexander, Barbara D.
Año de publicación
2010
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.
Fil: Pfeiffer, Christopher D.. University of Duke; Estados Unidos
Fil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados Unidos
Fil: Zaas, Aimee K.. University of Duke; Estados Unidos
Fil: Perfect, John R.. University of Duke; Estados Unidos
Fil: Perlin, David S.. State University of New Jersey; Estados Unidos
Fil: Alexander, Barbara D.. University of Duke; Estados Unidos
Materia
Echinocandinas
Resistencia
Candida
micafungina
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/100414

id CONICETDig_e4c9d3fb958b111163676d0c831eb638
oai_identifier_str oai:ri.conicet.gov.ar:11336/100414
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Breakthrough Invasive Candidiasis in Patients on MicafunginPfeiffer, Christopher D.Garcia, Guillermo ManuelZaas, Aimee K.Perfect, John R.Perlin, David S.Alexander, Barbara D.EchinocandinasResistenciaCandidamicafunginahttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.Fil: Pfeiffer, Christopher D.. University of Duke; Estados UnidosFil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados UnidosFil: Zaas, Aimee K.. University of Duke; Estados UnidosFil: Perfect, John R.. University of Duke; Estados UnidosFil: Perlin, David S.. State University of New Jersey; Estados UnidosFil: Alexander, Barbara D.. University of Duke; Estados UnidosAmerican Society for Microbiology2010-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/100414Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-23800095-1137CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.02390-09info:eu-repo/semantics/altIdentifier/url/https://jcm.asm.org/content/48/7/2373.longinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897493/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:04:56Zoai:ri.conicet.gov.ar:11336/100414instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:04:56.786CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Breakthrough Invasive Candidiasis in Patients on Micafungin
title Breakthrough Invasive Candidiasis in Patients on Micafungin
spellingShingle Breakthrough Invasive Candidiasis in Patients on Micafungin
Pfeiffer, Christopher D.
Echinocandinas
Resistencia
Candida
micafungina
title_short Breakthrough Invasive Candidiasis in Patients on Micafungin
title_full Breakthrough Invasive Candidiasis in Patients on Micafungin
title_fullStr Breakthrough Invasive Candidiasis in Patients on Micafungin
title_full_unstemmed Breakthrough Invasive Candidiasis in Patients on Micafungin
title_sort Breakthrough Invasive Candidiasis in Patients on Micafungin
dc.creator.none.fl_str_mv Pfeiffer, Christopher D.
Garcia, Guillermo Manuel
Zaas, Aimee K.
Perfect, John R.
Perlin, David S.
Alexander, Barbara D.
author Pfeiffer, Christopher D.
author_facet Pfeiffer, Christopher D.
Garcia, Guillermo Manuel
Zaas, Aimee K.
Perfect, John R.
Perlin, David S.
Alexander, Barbara D.
author_role author
author2 Garcia, Guillermo Manuel
Zaas, Aimee K.
Perfect, John R.
Perlin, David S.
Alexander, Barbara D.
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Echinocandinas
Resistencia
Candida
micafungina
topic Echinocandinas
Resistencia
Candida
micafungina
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.
Fil: Pfeiffer, Christopher D.. University of Duke; Estados Unidos
Fil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados Unidos
Fil: Zaas, Aimee K.. University of Duke; Estados Unidos
Fil: Perfect, John R.. University of Duke; Estados Unidos
Fil: Perlin, David S.. State University of New Jersey; Estados Unidos
Fil: Alexander, Barbara D.. University of Duke; Estados Unidos
description For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.
publishDate 2010
dc.date.none.fl_str_mv 2010-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/100414
Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-2380
0095-1137
CONICET Digital
CONICET
url http://hdl.handle.net/11336/100414
identifier_str_mv Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-2380
0095-1137
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.02390-09
info:eu-repo/semantics/altIdentifier/url/https://jcm.asm.org/content/48/7/2373.long
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897493/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846782400687767552
score 12.982451